Andrew Robbins owns 0.38% of Cogent Biosciences
657,503 shares as of the May 19, 2026 filing, worth $19.4M at the latest close.
COGT · $5.1B market capGet an email when Andrew Robbins’s stake moves.
Free.
The stake
0.38%
worth $19.4M at the latest close
Stake rank
#1,260
by dollar value of the stake
Last sale
None
no sales since 2016
Last buy
None
no purchases since 2016
Andrew Robbins owns 0.38% of Cogent Biosciences, Inc.: 657,503 of 173,524,982 shares, worth about $19.4M at the 2026-10-16 close. The stake has moved from 0.00% in 2020 to 0.38% on 2026-08-06.
How the stake is held
as of the May 19, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated May 19, 2026 · Form 4 ↗
HELD DIRECTLY
497,503
75.7%
HELD INDIRECTLY · By trust
160,000
24.3%
THE STAKE
657,503
0.38%